Former investment banker turned private investor Ian Yoong thinks there could be a buying opportunity if indeed there is positive news of a reversal of inventory impairments.
IT wasn’t that long ago, when a number of listed companies were racing to get involved in Covid-19 related businesses.
These included companies getting involved in vaccine production and distribution at a time when there were seemingly shortages of vaccines and growing demand for what was deemed as life saving therapy.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
